Cargando…
Clinical characteristics and vaccine effectiveness against SARS-CoV-2 Omicron subvariant BA.2 in the children
Autores principales: | Li, Xiaohe, Wu, Liwen, Qu, Youzhi, Cao, Mengli, Feng, Jiaqi, Huang, Hua, Liu, Yi, Lu, Hongzhou, Liu, Quanying, Liu, Yingxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240082/ https://www.ncbi.nlm.nih.gov/pubmed/35764610 http://dx.doi.org/10.1038/s41392-022-01023-w |
Ejemplares similares
-
Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5
por: Kimura, Izumi, et al.
Publicado: (2022) -
Antigenic characterization of the SARS-CoV-2 Omicron subvariant BA.2.75
por: Wang, Qian, et al.
Publicado: (2022) -
Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants
por: Qu, Panke, et al.
Publicado: (2022) -
Vitamin D levels and clinical outcomes of SARS-CoV-2 Omicron subvariant BA.2 in children: A longitudinal cohort study
por: Peng, Denggao, et al.
Publicado: (2022) -
Antigenic characterization of SARS-CoV-2 Omicron subvariant BA.4.6
por: Dijokaite-Guraliuc, Aiste, et al.
Publicado: (2022)